FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

AvKARE Cinacalcet Tablets Recall

Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski,…

AvKARE · Pulaski, TN

Risk level
Class II
Reported by FDA
Dec 11, 2024
Recall ID
D-0109-2025
Check your lot numberHow we source this data

Summary

AvKARE recalled Cinacalcet Tablets starting Nov 27, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0109-2025 on Dec 11, 2024. Reason: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit. Status: Ongoing.

Why it was recalled

CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.

Product description

Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30

Lot numbers, UPCs & expiration codes

Lot # 44550, Exp 12/31/2024

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0109-2025
Classification
Class II
Status
Ongoing
Recall initiated
Nov 27, 2024
FDA report date
Dec 11, 2024
Quantity
2,396 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
AvKARE

Original FDA data

Every field from FDA enforcement report D-0109-2025, exactly as published.

Show all FDA fields
City
Pulaski
State
TN
Status
Ongoing
Country
United States
Event ID
95897
Address
615 N 1st St
Code information
Lot # 44550, Exp 12/31/2024
Postal code
38478-2403
Report date
Dec 11, 2024
Product type
Drugs
Recall number
D-0109-2025
Classification
Class II
Recalling firm
AvKARE
Product quantity
2,396 bottles
Reason for recall
CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30
Distribution pattern
USA Nationwide
Recall initiation date
Nov 27, 2024
Initial firm notification
Letter
Center classification date
Dec 5, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0109-2025, published Dec 11, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls